You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 00078-0432


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00078-0432

Drug NameNDCPrice/Unit ($)UnitDate
FOCALIN XR 20 MG CAPSULE 00078-0432-05 4.90275 EACH 2025-03-19
FOCALIN XR 20 MG CAPSULE 00078-0432-05 4.90304 EACH 2024-11-20
FOCALIN XR 20 MG CAPSULE 00078-0432-05 4.90121 EACH 2024-10-23
FOCALIN XR 20 MG CAPSULE 00078-0432-05 4.89893 EACH 2024-09-18
FOCALIN XR 20 MG CAPSULE 00078-0432-05 4.90397 EACH 2024-08-21
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 00078-0432

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
FOCALIN XR 20MG CAP Novartis Pharmaceuticals Corporation 00078-0432-05 100 1302.44 13.02440 2020-09-01 - 2025-08-31 FSS
FOCALIN XR 20MG CAP Novartis Pharmaceuticals Corporation 00078-0432-05 100 1302.44 13.02440 2021-01-01 - 2025-08-31 FSS
FOCALIN XR 20MG CAP Sandoz, Inc. 00078-0432-05 100 1054.28 10.54280 2024-01-01 - 2028-08-14 FSS
FOCALIN XR 20MG CAP Sandoz, Inc. 00078-0432-05 100 998.14 9.98140 2023-09-29 - 2028-08-14 FSS
FOCALIN XR 20MG CAP Novartis Pharmaceuticals Corporation 00078-0432-05 100 987.76 9.87760 2022-01-01 - 2025-08-31 Big4
FOCALIN XR 20MG CAP Novartis Pharmaceuticals Corporation 00078-0432-05 100 983.32 9.83320 2021-01-01 - 2025-08-31 Big4
FOCALIN XR 20MG CAP Novartis Pharmaceuticals Corporation 00078-0432-05 100 913.96 9.13960 2020-09-01 - 2025-08-31 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 7 of 7 entries

Market Analysis and Price Projections for the Drug NDC: 00078-0432

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a drug identified by the National Drug Code (NDC) 00078-0432, it is crucial to understand what the NDC represents and how it is structured.

  • NDC Structure: The NDC is a unique, three-segment number that identifies the labeler, product, and package size of a drug. The first segment is the labeler code, assigned by the FDA, which identifies the firm that manufactures, repacks, or distributes the drug. The second segment is the product code, assigned by the firm, which identifies the specific strength, dosage form, and formulation of the drug. The third segment is the package code, also assigned by the firm, which identifies the package sizes and types[1][4].

Identifying the Drug

To conduct a market analysis, you first need to identify the drug associated with the NDC 00078-0432.

  • Labeler Code: The first segment of the NDC (00078) identifies the labeler. This code is assigned by the FDA and can be looked up in the FDA's NDC Directory to determine the firm responsible for the drug.
  • Product Code: The second segment identifies the specific drug product, including its strength, dosage form, and formulation.
  • Package Code: The third segment specifies the package size and type.

Market Analysis

Current Pricing

To analyze the current market price of the drug, you would typically refer to databases that track drug prices, such as those provided by DrugPatentWatch or other pharmaceutical pricing resources.

  • Price Trends: Historical price data can help in understanding how the price of the drug has fluctuated over time. For example, if the price has been increasing, it might be due to factors such as increased demand, supply chain disruptions, or changes in raw material costs[5].

Example of Price Fluctuations

While the specific data for NDC 00078-0432 is not provided here, an example from another drug (DAPSONE 5% GEL, NDC 51672-1387) shows how prices can vary:

  • Prices for DAPSONE 5% GEL have fluctuated between $1.37 and $1.84 per gram over different dates, indicating market dynamics and potential changes in supply or demand[5].

Factors Influencing Price Projections

Research and Development Costs

Pharmaceutical companies often offset the costs of research and development, as well as increases in active pharmaceutical ingredients (APIs), materials, and other supplies, by adjusting the prices of their drugs. This is a common practice seen in the industry[3].

Regulatory and Transparency Requirements

States like Oregon have implemented drug price transparency programs, which require manufacturers to report price increases and provide reasons for these increases. Such regulations can impact pricing strategies and transparency in the market[2].

Supply Chain Dynamics

The pharmaceutical supply chain involves various entities, including manufacturers, pharmacy benefit managers (PBMs), and health insurers. Interactions and financial negotiations among these entities can significantly influence drug prices. For instance, rebates, discounts, and fees can all play a role in the final cost to consumers[2].

Market Competition

The level of competition in the market, including the presence of generic alternatives, can also affect price projections. Generic drugs often have lower prices and can drive down the prices of brand-name drugs[2].

Price Projections

Historical Data Analysis

Analyzing historical price data for the drug can help in projecting future prices. If the drug has shown a consistent increase in price over the years, it is likely that this trend will continue unless there are significant changes in the market or regulatory environment.

Industry Trends

Understanding broader industry trends, such as the overall increase in prescription drug prices, can also inform price projections. For example, the Oregon Drug Price Transparency Program reported median price increases of 19.9% for generic drugs and 13.4% for brand-name drugs in 2022[2].

Economic Factors

Economic factors such as inflation, changes in raw material costs, and global economic conditions can also impact drug prices. For instance, increases in API costs or other materials can lead to higher drug prices[3].

Conclusion

Market analysis and price projections for a drug like the one identified by NDC 00078-0432 involve a comprehensive look at the drug's current pricing, historical trends, and the various factors influencing its price. Here are some key points to consider:

  • Identify the Drug: Use the NDC to identify the labeler, product, and package size.
  • Current Pricing: Refer to databases that track drug prices.
  • Historical Trends: Analyze past price fluctuations to predict future trends.
  • Regulatory and Supply Chain Factors: Consider the impact of transparency programs, supply chain dynamics, and regulatory changes.
  • Market Competition: Evaluate the presence of generic alternatives and their impact on pricing.
  • Economic Factors: Account for inflation, raw material costs, and global economic conditions.

Key Takeaways

  • NDC Structure: The NDC is a three-segment number identifying the labeler, product, and package size.
  • Market Analysis: Historical price data, regulatory requirements, supply chain dynamics, market competition, and economic factors are crucial for analysis.
  • Price Projections: Use historical trends, industry analysis, and economic factors to project future prices.

FAQs

Q: What does the NDC 00078-0432 represent? A: The NDC 00078-0432 is a unique identifier for a specific drug product, including its labeler, product details, and package size.

Q: How do I find the current price of a drug using its NDC? A: You can find the current price by referring to pharmaceutical pricing databases or resources like DrugPatentWatch.

Q: What factors influence the price of prescription drugs? A: Factors include research and development costs, regulatory requirements, supply chain dynamics, market competition, and economic conditions.

Q: How do state transparency programs affect drug pricing? A: State transparency programs, like Oregon's, require manufacturers to report price increases and provide reasons, which can impact pricing strategies and transparency.

Q: Can generic drugs affect the price of brand-name drugs? A: Yes, the presence of generic alternatives can drive down the prices of brand-name drugs due to increased competition.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.